CNinsure

Piper Jaffray reiterated its Underweight rating on CNinsure (NASDAQ: CISG). In a research report published today, Piper Jaffray lowered its earnings per share estimates for the next two years, in spite of the company's better than expected Q1 results. In the report, Piper Jaffray states, "CISG...

Brean Murray Carret & Company has lowered the price target on CNinsure (NASDAQ: CISG) from $24 to $19 and maintains its Buy rating.

Oppenheimer has moved CNinsure (NYSE: CISG) to Not Rated following the company's receiving of a "going private" proposal from Chairman & CEO Yinan Yu, CDH, along with TPG Asia, with a $19/share offer.

J.P. Morgan is out with its report today on CNinsure (NASDAQ: CISG), maintaining Underweight, as CISG announced that it received an offer to privatize. In a note to clients, J.P. Morgan writes, "Given that CNinsure only requires another one-third of its shareholders to approve the transaction...

Piper Jaffray is out with its report today on CNinsure (NASDAQ: CISG), maintaining Underweight as CISG announced a proposal to go private. In a note to clients, Piper Jaffray writes, "In our view, shareholders should vote for such a proposal in the event a definitive agreement comes to pass. The...

Bank of America Merrill Lynch is out with its report today on CNinsure (NASDAQ: CISG), moving CISG to no-rating. In a note to clients, Bank of America Merrill Lynch writes, "CNinsure announced that it has received a preliminary non-binding proposal from TPG, Kingsford Resources Limited (controlled...

J.P. Morgan is out with its report today on CNinsure (NASDAQ: CISG), downgrading shares of CISG from Neutral to Underweight. In a note to clients, J.P. Morgan writes, "We cut our 2012E/2013E earnings forecast by 25%/32% on the loss of revenue from Datong and higher expenses, ahead of the analyst...

JP Morgan has downgraded CNinsure, Inc. (NASDAQ: CISG) from Neutral to Underweight and has lowered the price target from $20 to $12.

Oppeneheimer has raised the price target on CNInsure, Inc. (NYSE: CISG) from $20 to $23 and maintains its Outperform rating. 

Oppenheimer has initiated coverage on CNinsure, Inc. (NASDAQ: CISG) with an Outperform rating and $23 price target.

Piper Jaffray has lowered the price target on CNinsure Inc. (NASDAQ: CISG) from $22 to $14.

Brean Murray Carret & Co. has initiated coverage for the following companies: Allos Therapeutics (NASDAQ: ALTH) Buy, $9 price target CNinsure (NASDAQ: CISG) Buy, $34 price target